Xiao-Shuan Liang
Overview
Explore the profile of Xiao-Shuan Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
62
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Niu M, Shan M, Liu Y, Song Y, Han J, Sun S, et al.
Front Oncol
. 2021 Jun;
11:641931.
PMID: 34113564
Breast cancer (BRCA) is one of the most deadly cancers worldwide, with poor survival rates that could be due to its high proliferation. Human all-alpha dCTP pyrophosphatase 1 (DCTPP1) is...
2.
Lei B, Xu S, Liang X, Li Y, Zhang J, Zhang G, et al.
Tumour Biol
. 2015 Nov;
37(4):5257-64.
PMID: 26555546
In recent years, with the development of transcriptomics, the effect of long non-coding RNAs (LncRNAs) on the regulation of biological processes is being elucidated. LncRNAs play an important role in...
3.
Tao W, Liang X, Liu Y, Wang C, Pang D
Int J Biol Sci
. 2015 Jan;
11(1):48-58.
PMID: 25552929
Low-dose metronomic (LDM) paclitaxel therapy displayed a stronger anti-angiogenic activity on breast tumors with fewer side effects. Upregulation of anti-angiogenic factor Thrombospondin-1 (TSP-1) accords for therapeutic potency of LDM paclitaxel,...
4.
Sun Q, Yang Y, Yu S, Zhang Y, He X, Sun S, et al.
Oncol Rep
. 2012 Sep;
28(6):2156-62.
PMID: 23007606
Copy number variation (CNV) is crucial for gene regulation in humans. A number of studies have revealed that CNV contributes to the initiation and progression of cancer. In this study,...